- Welcome to Specialised Therapeutics
-
SE Asia
+65 3158 9940
-
1300 798 820
-
New Zealand
+64 9801 0299
February 2008 - ST – Abraxis Bioscience Partnership
ST acquires exclusive Australian rights to market foundation product ABRAXANE® (nanoparticle-albumin bound paclitaxel)